Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.024 | 0.7 |